PDB-code
Browse PDE entries (page 5 of 31)
First 2 3 PreviousLast9 8 7 Next| # | Species | PDE Type | PDB | Chain | Alternate Model | Ligand | Details | File |
|---|---|---|---|---|---|---|---|---|
 | Human | PDE10 | 4lm0 | A | B | 5-NITROINDAZOLE |  | |
| Human | PDE10 | 4lm0 | B | A | | ||
| Human | PDE10 | 4lm0 | B | B | | ||
| Human | PDE10 | 4lm1 | A | A | 5-nitroquinoline | | |
| Human | PDE10 | 4lm1 | A | B | 5-nitroquinoline | | |
| Human | PDE10 | 4lm1 | B | A | | ||
| Human | PDE10 | 4lm1 | B | B | | ||
| Human | PDE10 | 4lm2 | A | A | 2,3-dihydro-1,4-benzodioxin-6-ylmethanol | | |
| Human | PDE10 | 4lm2 | A | B | 2,3-dihydro-1,4-benzodioxin-6-ylmethanol | | |
| Human | PDE10 | 4lm2 | B | A | | ||
| Human | PDE10 | 4lm2 | B | B | | ||
| Human | PDE10 | 4lm3 | A | A | 1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone | | |
| Human | PDE10 | 4lm3 | A | B | 1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone | | |
| Human | PDE10 | 4lm3 | B | A | | ||
| Human | PDE10 | 4lm3 | B | B | | ||
| Human | PDE10 | 4lm4 | A | A | quinazolin-4(1H)-one | | |
| Human | PDE10 | 4lm4 | A | B | quinazolin-4(1H)-one | | |
| Human | PDE10 | 4lm4 | B | A | | ||
| Human | PDE10 | 4lm4 | B | B | | ||
| Human | PDE10 | 4mrw | A | A | 7-chloroquinolin-4-ol | | |
| Human | PDE10 | 4mrw | A | B | 7-chloroquinolin-4-ol | | |
| Human | PDE10 | 4mrw | B | A | | ||
| Human | PDE10 | 4mrw | B | B | | ||
| Human | PDE10 | 4mrz | A | A | 4-methyl-3-nitropyridin-2-amine | | |
| Human | PDE10 | 4mrz | A | B | 4-methyl-3-nitropyridin-2-amine | | |
| Human | PDE10 | 4mrz | B | A | | ||
| Human | PDE10 | 4mrz | B | B | | ||
| Human | PDE10 | 4ms0 | A | A | 6-chloropyrimidine-2,4-diamine | | |
| Human | PDE10 | 4ms0 | A | B | 6-chloropyrimidine-2,4-diamine | | |
| Human | PDE10 | 4ms0 | B | A | |
This research was performed as part of the "Phosphodiesterase inhibitors for neglected parasitic diseases" (PDE4NPD) programme, which is supported by the European Union 7th Framework Program (FP7/2007-2013) under grant agreement n° 602666.
